➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Colorcon
Moodys
Merck
Dow
Boehringer Ingelheim
Express Scripts

Last Updated: June 25, 2021

DrugPatentWatch Database Preview

Drugs in Development Information for Tamibarotene


Email this page to a colleague

« Back to Dashboard

What is the drug development status for Tamibarotene?

Tamibarotene is an investigational drug.

There have been 9 clinical trials for Tamibarotene. The most recent clinical trial was a Phase 2 trial, which was initiated on February 8th 2021.

The most common disease conditions in clinical trials are Leukemia, Syndrome, and Preleukemia. The leading clinical trial sponsors are CytRx, Syros Pharmaceuticals, and Osaka City University.

There are four hundred and twenty-eight US patents protecting this investigational drug and three international patents.

Recent Clinical Trials for Tamibarotene
TitleSponsorPhase
SY-1425 Plus Azacitidine in Participants With Newly Diagnosed RARA-positive Higher-Risk Myelodysplastic SyndromeSyros PharmaceuticalsPhase 3
A Biomarker-Directed Phase 2 Trial of SY-1425 in Patients With Acute Myeloid Leukemia or Myelodysplastic SyndromeSyros PharmaceuticalsPhase 2
First Line Study of Tamibarotene in Combination for Advanced Non-Small Cell Lung CancerCytRxPhase 2

See all Tamibarotene clinical trials

Clinical Trial Summary for Tamibarotene

Top disease conditions for Tamibarotene
Top clinical trial sponsors for Tamibarotene

See all Tamibarotene clinical trials

US Patents for Tamibarotene

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Tamibarotene   Get Started Free Anticancer agent Kyoto Pharmaceutical Industries, Ltd. (Kyoto, JP) Sumitomo Dainippon Pharma Co., Ltd. (Osaka, JP)   Get Started Free
Tamibarotene   Get Started Free Pyrrolidinone derivatives as MetAP-2 inhibitors Merck Patent GmbH (Darmstadt, DE)   Get Started Free
Tamibarotene   Get Started Free .beta.-substituted .beta.-amino acids and analogs as chemotherapeutic agents and uses thereof Quadriga Biosciences, Inc. (Los Altos, CA)   Get Started Free
Tamibarotene   Get Started Free Antibody drug conjugates (ADCs) with kinesin spindel protein (KSP) BAYER PHARMA AKTIENGESELLSCHAFT (Berlin, DE)   Get Started Free
Tamibarotene   Get Started Free Aryl-cyanoguanidine compounds Bayer Pharma Aktiengesellschaft (Berlin, DE)   Get Started Free
Tamibarotene   Get Started Free Heteroaryl compounds as IRAK inhibitors and uses thereof Merck Patent GmbH (Darmstadt, DE)   Get Started Free
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for Tamibarotene

Drugname Country Document Number Estimated Expiration Related US Patent
Tamibarotene Australia AU2015272560 2034-06-09   Get Started Free
Tamibarotene Canada CA2951627 2034-06-09   Get Started Free
Tamibarotene Denmark DK3153508 2034-06-09   Get Started Free
Tamibarotene European Patent Office EP3153508 2034-06-09   Get Started Free
Tamibarotene Japan JP2019206529 2034-06-09   Get Started Free
Tamibarotene Japan JP6549115 2034-06-09   Get Started Free
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Moodys
AstraZeneca
Medtronic
McKesson
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.